Login

BlackRock Favors Japan Stocks | Hiroyuki Shimizu, CEO, BlackRock Japan Co. Ltd.AS OF 07 MAR 2024 00:10:00

Share On Facebook Share On Twitter

Hiroyuki Shimizu is the CEO of BlackRock Japan Co. Ltd.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Max Cooper, recipient of the 2019 Colonial First State Sports Booster award.
00:10:00
Breaking Barriers, Building Empires: The Untold Story of Women in VC|Adina Davis,Principal,BoxGroup
00:00:00
Aram Mangasarian , CEO, NOXXON Pharma
00:10:00
Unique Cell Therapy Platform's Promise| Steven Kelly, CEO,Carisma Therapeutics Inc.
00:10:00
Vision and Future Strategies of Convergenze SpA: Insights from CEO Rosario Pingaro | Rosario Pingaro, CEO, Convergenze SpA Società Benefit.
00:10:00
Brief Overview of Mixed Audio Recording Transcript
00:10:00
Navigating Multi-Strategy Asset Allocation: Insights from Industry Leaders at SALT 2019 | Keith Haydon, Troy Gayeski, Joshua S. Friedman, John Graham
00:10:00
Testimonial on the Benefits of Using One-to-One IR for Investor Relations
00:10:00
Bannerman Energy: Advancing Namibia's Shovel-Ready Uranium Project
00:10:00
Etherstack CEO David Deacon Delivers Insights on MCPTT and IWF Solutions at CCW 2023 | DAVID DEACON, CEO of Etherstack PLC
00:10:00
At Blackstone we deliver for investors by building businesses that power tomorrow’s economy|Stephen A. Schwarzman,Chairman,The Blackstone Group
00:10:00
Financial Therapy with Rick Kahler | Rick Kahler - Founder and President of Kahler Financial Group

© 2017 - Neuhu+